AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries
Authors: Olsen, JH Hahnemann, JM Borresen-Dale, AL Brondum-Nielsen, K Hammarstrom, L Kleinerman, R Kaatriainen, H Lonnqvist, T Sankila, R Seersholm, N Tretli, S Yuen, J Boice, JD Tucker, M
Citation: Jh. Olsen et al., Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries, J NAT CANC, 93(2), 2001, pp. 121-127
Low frequency of E-cadherin alterations in familial breast cancer
Authors: Salahshor, S Lei, HX Huo, HG Kristensen, VN Loman, N Sjoberg-Margolin, S Borg, A Borresen-Dale, AL Vorechovsky, I Lindblom, A
Citation: S. Salahshor et al., Low frequency of E-cadherin alterations in familial breast cancer, BREAST CA R, 3(3), 2001, pp. 199-207
Genetic susceptibility and environmental estrogen-like compounds
Authors: Kristensen, VN Kure, EH Erikstein, B Harada, N Borresen-Dale, AL
Citation: Vn. Kristensen et al., Genetic susceptibility and environmental estrogen-like compounds, MUT RES-F M, 482(1-2), 2001, pp. 77-82
Microarrays in primary breast cancer - lessons from chemotherapy studies
Authors: Lonning, PE Sorlie, T Perou, CM Brown, PO Botstein, D Borresen-Dale, AL
Citation: Pe. Lonning et al., Microarrays in primary breast cancer - lessons from chemotherapy studies, ENDOCR-R CA, 8(3), 2001, pp. 259-263
Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations
Authors: Bjorheim, J Ekstrom, PO Fossberg, E Borresen-Dale, AL Gaudernack, G
Citation: J. Bjorheim et al., Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations, BIOTECHNIQU, 30(5), 2001, pp. 972-975
High-throughput methods for detection of genetic variation
Authors: Kristensen, VN Kelefiotis, D Kristensen, T Borresen-Dale, AL
Citation: Vn. Kristensen et al., High-throughput methods for detection of genetic variation, BIOTECHNIQU, 30(2), 2001, pp. 318
Gene expression patterns of breast carcinomas distinguish tumor subclasseswith clinical implications
Authors: Sorlie, T Perou, CM Tibshirani, R Aas, T Geisler, S Johnsen, H Hastie, T Eisen, MB van de Rijn, M Jeffrey, SS Thorsen, T Quist, H Matese, JC Brown, PO Botstein, D Lonning, PE Borresen-Dale, AL
Citation: T. Sorlie et al., Gene expression patterns of breast carcinomas distinguish tumor subclasseswith clinical implications, P NAS US, 98(19), 2001, pp. 10869-10874
Quantitative analysis of chromosomal CGH in human breast tumors associatescopy number abnormalities with p53 status and patient survival
Authors: Jain, AN Chin, K Borresen-Dale, AL Erikstein, BK Lonning, PE Kaaresen, R Gray, JW
Citation: An. Jain et al., Quantitative analysis of chromosomal CGH in human breast tumors associatescopy number abnormalities with p53 status and patient survival, P NAS US, 98(14), 2001, pp. 7952-7957
Influence of TP53 gene alterations and c-erbB-2 expression on the responseto treatment with doxorubicin in locally advanced breast cancer
Authors: Geisler, S Lonning, PE Aas, T Johnsen, H Fluge, O Haugen, DF Lillehaug, JR Akslen, LA Borresen-Dale, AL
Citation: S. Geisler et al., Influence of TP53 gene alterations and c-erbB-2 expression on the responseto treatment with doxorubicin in locally advanced breast cancer, CANCER RES, 61(6), 2001, pp. 2505-2512
Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism
Authors: Kristensen, VN Borresen-Dale, AL
Citation: Vn. Kristensen et Al. Borresen-dale, Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism, MUT RES-R M, 462(2-3), 2000, pp. 323-333
Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia
Authors: Laake, K Jansen, L Hahnemann, JM Brondum-Nielsen, K Lonnqvist, T Kaariainen, H Sankila, R Lahdesmaki, A Hammarstrom, L Yuen, J Tretli, S Heiberg, A Olsen, JH Tucker, M Kleinerman, R Borresen-Dale, AL
Citation: K. Laake et al., Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia, HUM MUTAT, 16(3), 2000, pp. 232-246
Genetic variants of CYP19 (aromatase) and breast cancer risk
Authors: Kristensen, VN Harada, N Yoshimura, N Haraldsen, E Lonning, P Erikstein, B Karesen, R Kristensen, T Borresen-Dale, AL
Citation: Vn. Kristensen et al., Genetic variants of CYP19 (aromatase) and breast cancer risk, ONCOGENE, 19(10), 2000, pp. 1329-1333
Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism
Authors: Jugessur, A Frost, P Andersen, TI Steine, S Lindblom, A Borresen-Dale, AL Eiken, HG
Citation: A. Jugessur et al., Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism, J MOL MED-J, 78(10), 2000, pp. 580-587
Association between apolipoprotein E genotypes and cancer risk in patientswith acquired immunodeficiency syndrome
Authors: Liestol, K Kvittingen, EA Rootwelt, H Dunlop, O Goplen, AK Pedersen, JC Brorson, SH Borresen-Dale, AL Myrvang, B Maehlen, J
Citation: K. Liestol et al., Association between apolipoprotein E genotypes and cancer risk in patientswith acquired immunodeficiency syndrome, CANCER DET, 24(5), 2000, pp. 496-499
Molecular portraits of human breast tumours
Authors: Perou, CM Sorlie, T Eisen, MB van de Rijn, M Jeffrey, SS Rees, CA Pollack, JR Ross, DT Johnsen, H Aksien, LA Fluge, O Pergamenschikov, A Williams, C Zhu, SX Lonning, PE Borresen-Dale, AL Brown, PO Botstein, D
Citation: Cm. Perou et al., Molecular portraits of human breast tumours, NATURE, 406(6797), 2000, pp. 747-752
Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients
Authors: Bukholm, IK Nesland, JM Borresen-Dale, AL
Citation: Ik. Bukholm et al., Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients, J PATHOLOGY, 190(1), 2000, pp. 15-19
Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell non-Hodgkin's lymphoma
Authors: Stokke, T Galteland, E Holte, H Smedshammer, L Suo, ZH Smeland, EB Borresen-Dale, AL DeAngelis, P Steen, HB
Citation: T. Stokke et al., Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell non-Hodgkin's lymphoma, INT J CANC, 89(4), 2000, pp. 313-324
Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RB1 and TP53 inrelation to survival
Authors: Helland, A Kraggerud, SM Kristensen, GB Holm, R Abeler, VM Huebner, K Borresen-Dale, AL Lothe, RA
Citation: A. Helland et al., Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RB1 and TP53 inrelation to survival, INT J CANC, 88(2), 2000, pp. 217-222
Screening breast cancer patients for Norwegian ATM mutations
Authors: Laake, K Vu, P Andersen, TI Erikstein, B Karesen, R Lonning, PE Skovlund, E Borresen-Dale, AL
Citation: K. Laake et al., Screening breast cancer patients for Norwegian ATM mutations, BR J CANC, 83(12), 2000, pp. 1650-1653
Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study
Authors: Laake, K Launonen, V Niederacher, D Gudlaugsdottir, S Seitz, S Rio, P Champeme, MH Bieche, I Birnbaum, D White, G Sztan, M Sever, N Plummer, S Osorio, A Broeks, A Huusko, P Spurr, N Borg, A Cleton-Jansen, AM van't Veer, L Benitez, J Casey, G Peterlin, B Olah, E Varley, J Bignon, YJ Scherneck, S Sigurdardottir, V Lidereau, R Eyfjord, J Beckmann, MW Winqvist, R Skovlund, E Borresen-Dale, AL
Citation: K. Laake et al., Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study, GENE CHROM, 25(3), 1999, pp. 212-221
Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients (vol 8, pg 441, 1998)
Authors: Kristensen, VN Andersen, TI Erikstein, B Geitvik, G Skovlund, E Nesland, JM Borresen-Dale, AL
Citation: Vn. Kristensen et al., Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients (vol 8, pg 441, 1998), PHARMACOGEN, 9(1), 1999, pp. 129-129
Allelic imbalance at chromosome region 11q23 in cervical carcinomas
Authors: Skomedal, H Helland, A Kristensen, GB Holm, R Borresen-Dale, AL
Citation: H. Skomedal et al., Allelic imbalance at chromosome region 11q23 in cervical carcinomas, EUR J CANC, 35(4), 1999, pp. 659-663
No association between radiosensitivity and TP53 status, G(1) arrest or protein levels of p53, myc, ras or raf in human melanoma lines
Authors: Danielsen, T Smith-Sorensen, B Gronlund, HA Hvidsten, M Borresen-Dale, AL Rofstad, EK
Citation: T. Danielsen et al., No association between radiosensitivity and TP53 status, G(1) arrest or protein levels of p53, myc, ras or raf in human melanoma lines, INT J RAD B, 75(9), 1999, pp. 1149-1160
TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas
Authors: Hogmo, A Borresen-Dale, AL Blegen, H Lindholm, J Kuylenstierna, R Auer, G Munck-Wikland, E
Citation: A. Hogmo et al., TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas, ANTICANC R, 19(4C), 1999, pp. 3433-3438
p53 polymorphism and cervical cancer
Authors: Helland, A Borresen-Dale, AL
Citation: A. Helland et Al. Borresen-dale, p53 polymorphism and cervical cancer, LANCET, 354(9189), 1999, pp. 1561-1562
Risultati: 1-25 | 26-31